Clinical Trial Update: Neocytolysis in the Treatment of Renal Anemia With Erythropoieses Stimulating Agents (ESA) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating neocytolysis in the treatment of anemia due to chronic kidney disease in patients receiving erythropoiesis-stimulating agents.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease

Drugs mentioned

• Erythropoiesis-stimulating agents (ESA) (erythropoiesis-stimulating agent)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Renal Anemia | Phase 4 | Status: COMPLETED